Top compounds associated with response to HSPA1L


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.092 0.004
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.089 0.006
mRNA pluripotin CTRPv2 pan-cancer AAC -0.098 0.006
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.007
mRNA ML320 CTRPv2 pan-cancer AAC -0.099 0.007
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.096 0.007
mRNA CX-5461 GDSC1000 pan-cancer AAC -0.084 0.007
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.076 0.008
mRNA Gemcitabine gCSI pan-cancer AAC -0.16 0.009
Download CSV